Gilead: Can HIV Franchise Sustain Revenue

Gilead Sciences, a leading biopharmaceutical company, has built a significant portion of its revenue around treatments for HIV. With the success of Truvada and other antiretroviral drugs, investors question whether this franchise can sustain its earnings in the face of…








